Issue 2/2011
Content (35 Articles)
Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73
Su Wei Wong, Kai Hung Tiong, Weng Yip Kong, Yuen Chee Yue, Choon Hooi Chua, Jae Ying Lim, Chai Yuin Lee, Sean I. Quah, Cindy Fow, Cyril Chung, Irene So, Boon Shing Tan, Heng Lungh Choo, Rozita Rosli, Soon-Keng Cheong, Chee-Onn Leong
RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype
Hany Onsy Habashy, Desmond G. Powe, Enrico Glaab, Graham Ball, Inmaculada Spiteri, Natalio Krasnogor, Jonathan M. Garibaldi, Emad A. Rakha, Andrew R. Green, C. Caldas, Ian O. Ellis
Accumulation of mutations over the entire mitochondrial genome of breast cancer cells obtained by tissue microdissection
Liane Fendt, Harald Niederstätter, Gabriela Huber, Bettina Zelger, Martina Dünser, Christof Seifarth, Alexander Röck, Georg Schäfer, Helmut Klocker, Walther Parson
CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo
Manuel Koch, Fadi Hussein, Andreas Woeste, Carsten Gründker, Karl Frontzek, Günter Emons, Thomas Hawighorst
Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer
Teemu T. Junttila, Guangmin Li, Kathryn Parsons, Gail Lewis Phillips, Mark X. Sliwkowski
Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth
Robert S. Tolhurst, Ross S. Thomas, Fiona J. Kyle, Hetal Patel, Manikandan Periyasamy, Andrew Photiou, Paul T. R. Thiruchelvam, Chun-Fui Lai, Marwa Al-sabbagh, Rosemary A. Fisher, Sayka Barry, Tatjana Crnogorac-Jurcevic, Lesley-Ann Martin, Mitch Dowsett, R. Charles Coombes, Tahereh Kamalati, Simak Ali, Laki Buluwela
The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy
Gabriel Farante, Stefano Zurrida, Viviana Galimberti, Paolo Veronesi, Giuseppe Curigliano, Alberto Luini, Aron Goldhirsch, Umberto Veronesi
Erratum to: The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy
Gabriel Farante, Stefano Zurrida, Viviana Galimberti, Paolo Veronesi, Giuseppe Curigliano, Alberto Luini, Aron Goldhirsch, Umberto Veronesi
Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts
Mamoru Nukatsuka, Hitoshi Saito, Fumio Nakagawa, Masaaki Abe, Junji Uchida, Jiro Shibata, Ken-ichi Matsuo, Shinzaburo Noguchi, Mamoru Kiniwa
Distinct function of androgen receptor coactivator ARA70α and ARA70β in mammary gland development, and in breast cancer
Xinyu Wu, Fei Chen, Aysegul Sahin, Constance Albarracin, Zhiheng Pei, Xuanyi Zou, Baljit Singh, Ruliang Xu, Garrett Daniels, Yirong Li, Jianjun Wei, Marvin Blake, Robert J. Schneider, Pamela Cowin, Peng Lee
Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial
F. P. O’Malley, S. Chia, D. Tu, L. E. Shepherd, M. N. Levine, D. Huntsman, V. H. Bramwell, I. L. Andrulis, K. I. Pritchard
Effects of music therapy on pain among female breast cancer patients after radical mastectomy: results from a randomized controlled trial
Xiao-Mei Li, Hong Yan, Kai-Na Zhou, Shao-Nong Dang, Duo-Lao Wang, Yin-Ping Zhang
Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control
Jeffrey M. Albert, Aman U. Buzdar, Reina Guzman, Pamela K. Allen, Eric A. Strom, George H. Perkins, Wendy A. Woodward, Karen E. Hoffman, Welela Tereffe, Kelly K. Hunt, Thomas A. Buchholz, Julia L. Oh
Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: a cross-sectional study on 4,292 consecutive patients
T. Vandorpe, A. Smeets, B. Van Calster, K. Van Hoorde, K. Leunen, F. Amant, Ph. Moerman, K. Deraedt, O. Brouckaert, S. Van Huffel, H. Wildiers, M. R. Christiaens, P. Neven
Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy
R. I. Lalisang, F. L. G. Erdkamp, C. J. Rodenburg, C. T. A. M. Knibbeler-van Rossum, J. W. R. Nortier, A. van Bochove, P. H. Th. J. Slee, E. E. Voest, J. A. Wils, J. Wals, O. J. L. Loosveld, A. E. M. Smals, G. H. Blijham, V. C. G. Tjan-Heijnen, H. C. Schouten
Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer
E. Razis, M. Bobos, V. Kotoula, A. G. Eleftheraki, H. P. Kalofonos, K. Pavlakis, P. Papakostas, G. Aravantinos, G. Rigakos, I. Efstratiou, K. Petraki, D. Bafaloukos, I. Kostopoulos, D. Pectasides, K. T. Kalogeras, D. Skarlos, G. Fountzilas
G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer
Atanas Ignatov, Tanja Ignatov, Christine Weißenborn, Holm Eggemann, Joachim Bischoff, Andrzej Semczuk, Albert Roessner, Serban Dan Costa, Thomas Kalinski
Current evidence on the relationship between HRAS1 polymorphism and breast cancer risk: a meta-analysis
Chun Zhang, Guo-Qiang Lv, Xian-Ming Yu, Yuan-Long Gu, Jian-Ping Li, Liang-Feng Du, Ping Zhou
Significant changes in dietary intake and supplement use after breast cancer diagnosis in a UK multicentre study
Louiza S. Velentzis, Mohammed R. Keshtgar, Jayne V. Woodside, Anthony J. Leathem, Ann Titcomb, Katherine Anne Perkins, Monika Mazurowska, Victoria Anderson, Kayleigh Wardell, Marie M. Cantwell
Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms
Julia Kravchenko, Igor Akushevich, Victoria L. Seewaldt, Amy P. Abernethy, H. Kim Lyerly
Improved survival of patients with primary distant metastatic breast cancer in the period of 1995–2008. A nationwide population-based study in the Netherlands
J. Ruiterkamp, M. F. Ernst, L. de Munck, M. van der Heiden-van der Loo, E. Bastiaannet, L. V. van de Poll-Franse, K. Bosscha, V. C. G. Tjan-Heijnen, A. C. Voogd
Image-guided sampling reveals increased stroma and lower glandular complexity in mammographically dense breast tissue
Suling J. Lin, Jennifer Cawson, Prue Hill, Izhak Haviv, Mark Jenkins, John L. Hopper, Melissa C. Southey, Ian G. Campbell, Erik W. Thompson
Socioeconomic inequalities in attending the mass screening for breast cancer in the south of the Netherlands—associations with stage at diagnosis and survival
M. J. Aarts, A. C. Voogd, L. E. M. Duijm, J. W. W. Coebergh, W. J. Louwman
Functional polymorphisms in CD166/ALCAM gene associated with increased risk for breast cancer in a Chinese population
Ping Zhou, Liang-Feng Du, Guo-Qiang Lv, Xian-Ming Yu, Yuan-Long Gu, Jian-Ping Li, Chun Zhang
Breast cancer screening and ethnicity in the United States: implications for health disparities research
Patricia Y. Miranda, Wassim Tarraf, Hector M. González
Breast cancers in U.S. residing Indian-Pakistani versus non-Hispanic White women: comparative analysis of clinical-pathologic features, treatment, and survival
Meena S. Moran, Lou Gonsalves, Donna M. Goss, Shuangge Ma
Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs)
Anne Oberguggenberger, Michael Hubalek, Monika Sztankay, Verena Meraner, Beate Beer, Herbert Oberacher, Johannes Giesinger, Georg Kemmler, Daniel Egle, Eva-Maria Gamper, Barbara Sperner-Unterweger, Bernhard Holzner
Breast cancer scalp metastasis as first metastatic site after scalp cooling: Two cases of occurrence after 7- and 9-year follow-up
Julie Lemieux, Christine Desbiens, Jean-Charles Hogue
Reproductive factors associated with mammographic density: a Korean co-twin control study
Joohon Sung, Yun-Mi Song, Jennifer Stone, Kayoung Lee, Donghun Lee
Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry
B. Graña, L. Fachal, E. Darder, J. Balmaña, T. Ramón y Cajal, I. Blanco, A. Torres, C. Lázaro, O. Diez, C. Alonso, M. Santamariña, A. Velasco, A. Teulé, A. Lasa, A. Blanco, A. Izquierdo, J. Borràs, S. Gutiérrez-Enríquez, A. Vega, J. Brunet
The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer
Steven A. Narod
Limited evidence supported the association of HRAS1 polymorphism with breast cancer risk
Xiujun Zhang, Mengchun Jia
Tumor necrosis factor-α 308 G/A polymorphism in breast cancer risk
Zhishan Ding, Fusheng Jiang, Xinghong Ding, Suhong Chen, Guiyuan Lv
Endothelial nitric oxide synthase (eNOS) G894T polymorphism is not associated with breast cancer risk: new evidence
Huazhou Fu, Yangqing Zhang, Li Jin, Zhishan Ding